Vyne Therapeutics Inc (NASDAQ:VYNE)
| 2.68 Delayed Data As of 1:04pm ET |  +0.09 / +3.47%Today’s Change | 1.99 Today|||52-Week Range 14.22 | -0.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 674.0K | 4.6M | 10.6M | |
| Depreciation And Amortization | 0.00 | 4.0K | 8.0K | 22.0K | ||
| Operating Expenses | Gross Income | 0.00 | -- | -- | -- | -- |
| General Expenses | 4.6M | 15.0M | 34.2M | 65.2M | ||
| Research And Development | 2.9M | 11.3M | 29.0M | 53.0M | ||
| Total Operating Expenses | 4.6M | 15.0M | 34.2M | 65.2M | ||
| Non-Operating Expenses | Operating Income | -4.6M | -14.3M | -29.6M | -54.5M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -4.6M | -14.1M | -29.1M | -51.4M | |
| Net Income | -4.6M | -14.1M | -29.1M | -51.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 21.4M | 23.0M | 23.0M | 21.7M | |
| Shares To Calculate EPS Diluted | 21.4M | 23.0M | 23.0M | 21.7M | ||
| Earnings Per Share | EPS | -$0.22 | -$0.61 | -$1.27 | -$2.37 | |
| EPS Diluted | -$0.22 | -$0.61 | -$1.27 | -$2.37 | ||
